WAS
ONC icon

WESPAC Advisors SoCal’s BeOne Medicines Ltd ONC Stock Holding History

WESPAC Advisors SoCal’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.89M Buy
5,156
+74
+1% +$25.3K 0.34% 66
2026
Q2 		$1.45M Buy
5,082
+157
+3% +$46.3K 0.26% 71
2026
Q1 		$1.46M Buy
4,925
+1,968
+67% +$637K 0.31% 68
2025
Q4 		$898K Sell
2,957
-158
-5% -$51.7K 0.18% 80
2025
Q3 		$1.06M Buy
+3,115
New +$946K 0.22% 72

Other funds holding ONC

AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CIA
Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

WESPAC Advisors SoCal's ONC Position: Q3 2026 in Review

WESPAC Advisors SoCal increased its BeOne Medicines Ltd (ONC) stake by 1.5% in Q3 2026, buying an estimated $25.3K and bringing the position to 5,156 shares worth $1.89M. The position accounts for 0.34% of the portfolio, ranked #66.

WESPAC Advisors SoCal first reported a position in ONC in Q3 2025 and has held it in 5 quarters since. 10 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • WESPAC Advisors SoCal held 5,156 shares of BeOne Medicines Ltd worth $1.89M as of Q3 2026.
  • WESPAC Advisors SoCal bought 74 BeOne Medicines Ltd shares in Q3 2026, an estimated $25.3K.
  • BeOne Medicines Ltd made up 0.34% of WESPAC Advisors SoCal's portfolio in Q3 2026, its #66 holding.
  • WESPAC Advisors SoCal first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 5 quarters since.
  • 10 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on WESPAC Advisors SoCal's 13F filing for Q3 2026, filed 13 Oct 2026.